Abstract
Patients undergoing regular dialysis therapy for end‐stage renal disease retain fluid during the interdialytic period, which is removed during dialysis. The aim of such fluid removal is to maintain a dry or target weight in the patient. This weight was defined as the lowest weight that the patient could tolerate without any intradialytic symptoms or hypotension at the termination of the treatment session. It may be more accurately defined as the weight at which there is no excess extracellular hydration in the tissues. The accurate assessment of patient dry weight can pose considerable difficulties due to the shape of the pressure–volume curve of the interstitial fluid spaces such that oedema may not be detectable until the interstitial volume has risen by ∼30% above normal, corresponding to 4–5 l. The interdialytic weight gain seen in patients may not simply be a result of hypervolaemia; gain in body weight as a result of improved nutrition, particularly following the initiation of regular dialysis therapy, may also contribute. With the trend towards shorter treatment sessions, a more restrained approach to the interdialytic control of sodium intake and the treatment of older patients, the tolerance of the high ultrafiltration rates required to remove the interdialytic weight gain is impaired in many patients, preventing the attainment of dry weight by the end of the treatment session. These factors result in overhydration and increased blood pressure and contribute to cardiac complications and mortality in dialysis patients [ 1– 3].

This publication has 30 references indexed in Scilit: